Analysis of Elamex S.A. de C.V. (ELAMF)
Elamex S.A. de C.V. (ELAMF) has been showing consistent price stability with the closing price remaining at 2.15000 for the past several days. The Relative Strength Index (RSI) indicator is at 100.00000, indicating an overbought condition.
The Moving Average Convergence Divergence (MACD) indicator is showing a slight decrease in momentum, with the MACD line at 0.01852 and the signal line at 0.02379. The MACD histogram is negative at -0.00528, suggesting a potential reversal in the short term.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all close to the current price, indicating a stable trend.
Overall, based on the RSI and MACD indicators, there may be a potential for a short-term correction or consolidation in the price of ELAMF. Traders and investors should closely monitor the price action and key support levels for any potential trading opportunities.
Earnings
The company's results for the quarter ending April 30, 2025, have not been provided at this time. The results for the quarter ending February 27, 2025, are with the Transfer Agent. The results for the quarter ending January 31, 2025, were reported after hours. The results for the quarter ending October 31, 2024, have not been provided at this time. The results for the quarter ending August 1, 2024, showed an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows the stock's performance over the past year, with a beta of 1.264 and a 52-week change of 6.853%.
Valuation metrics reveal the company's price-to-earnings ratios, enterprise value, and market capitalization. The company's stock is trading at a relatively high price-to-book ratio and price-to-sales ratio.
Lastly, dividends and splits information shows the company's dividend history, payout ratio, and dividend yield. The company has a regular dividend payout and has undergone a stock split in the past.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. Financing activities show significant variations, with large amounts being spent on common stock repurchase and debt issuance/payment.
4. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
5. The end cash position has been fluctuating, but overall, the company has maintained a healthy cash balance.
6. Interest paid and income tax paid figures show the financial obligations of the company.
7. Stock-based compensation is a significant non-cash item that impacts the company's financials.
8. The company has been paying dividends consistently over the years, affecting its financing cash flow.
9. The company has engaged in acquisitions and other investing activities, impacting its cash flow position.
10. Overall, the company's cash flow statement reflects its financial health, operational performance, and strategic decisions over the years.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates show an increase compared to the year-ago EPS figures, indicating potential growth in earnings for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the past 5 years. However, the company is still projected to experience healthy growth both in the short and long term according to analyst consensus.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a wide range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price of the security is $191.57, which is below the median and average forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, with gross profit ranging from around $105 billion to $169 billion.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing over the years, from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a slight fluctuation but have generally increased from $3.28 in 2020 to $6.16 in 2023.
6. The company has been able to maintain a healthy EBITDA margin, with EBITDA reaching $129.2 billion in 2023.
7. Despite an increase in income tax expenses, the company has managed to grow its net income continuously.
8. The company has been able to control its operating expenses effectively, allowing for growth in operating income.
9. Non-operating interest expenses have been relatively stable over the years.
10. The number of basic and diluted shares outstanding has remained constant, indicating no significant dilution of shares.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,755,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $302,083,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company seems to be investing more in non-current assets over the years, which might indicate long-term growth strategies.
7. The increase in total liabilities suggests that the company is relying more on external funding sources.
8. The fluctuations in shareholders' equity indicate changes in the company's retained earnings and investments.
9. Overall, the company's financial position seems to be stable, but further analysis would be needed to assess its financial health accurately.MACD of ELAMF